The medicine Orlistat 60 mg manufactured by famous Healing Pharma is safe only while performing the doctor-approved exercise, behavior change, and performing a low-calorie diet program. This combination shall eventually help in losing weight effectively and safely. Long term treatment with consumption of orlistat has been shown significantly that shall lower weight and waist circumference for having beneficial effects on blood pressure, lipids, and type 2 diabetes. The medicine is safe for consumption by certain overweight people that are obese or might have weight-related medical issues. The section of capsules contains:

• Orlistat 60 mg
• Orlistat 120 mg

The recommended dose is one medicine with each main meal. Very little of the dose is absorbed while consumption as prescribed. The effect of this weight-loss medicine orlistat on fecal fat can be seen within two days. Some of the metabolism might also take place within the wall of the gut, but most of the medicine is excreted unchanged in the feces.

As consumption of Orlistat might lower the fat absorption most of the patients might develop adverse effects including fatty stools, fecal urgency, loose stools, flatulence, and incontinence. Most of the approximately 9% of patients that have discontinued treatment because of some adverse effects might be because of gastrointestinal problems.

Although the weight-loss medicine lowers cholesterol concentrations, it also lowers the absorption of some fat-soluble vitamins. Lowered vitamin K absorption can even alter the control of patients consuming warfarin. In various clinical trials, no deficiencies developed so vitamin supplements might not be required.

Orlistat is known for enhancing the plasma concentration of pravastatin, it also does not alter the pharmacokinetics of digoxin, glibenclamide or phenytoin. Acarbose that acts on intestinal glucosidase enzymes, should not be prescribed while being treated with orlistat as the potential for interactions has not been studied.

Some of the pooled data have also revealed in more cases of breast cancer in women consuming orlistat than in those taking a placebo. Some of the clinical relevance of this observation is uncertain, as is the effect of exposing the colonic mucosa to the large amounts of consuming fat.

Symptoms while consumption of this weight-loss medicine is usually mild that shall occur at the beginning of treatment and they have particularly experienced post consumption of meals with high levels of fat. Normally, such symptoms might disappear if you continue treatment and keep the medicine consumption with the recommended diet and physical exercise.